Eighteen deep technology companies building the next generation of energy, computing, and health infrastructure. All backed at the seed stage with $5M investment.
Solid-state battery technology enabling 3x energy density improvements for grid-scale storage and electric aviation. Patented electrolyte chemistry developed at ETH Zurich. Active partnerships with European grid operators.
United Kingdom • Seed Round, January 2025 • $5M
Advanced plasma confinement technology for compact fusion reactors. Novel magnetic coil geometry reduces capital cost by 60% versus conventional tokamak designs. First commercial demonstration unit targeting 2028.
Germany • Seed Round, September 2024 • $5M
AI-powered demand response and grid balancing platform for distributed energy resources. Aggregates and optimises over 2GW of virtual power plant capacity across Germany, France, and the Netherlands.
Netherlands • Seed Round, March 2024 • $5M
Direct air capture system using novel sorbent materials achieving cost below $180/tonne CO2 at scale. Modular architecture enables deployment in distributed settings without large capital infrastructure requirements.
Sweden • Seed Round, June 2023 • $5M
High-performance proton exchange membrane electrolyser technology with 94% efficiency rating. Catalyst formulation reduces platinum group metal usage by 80%, dramatically lowering system cost and securing supply chain resilience.
Denmark • Seed Round, November 2022 • $5M
Phase-change materials for passive thermal management in commercial buildings. Technology reduces HVAC energy consumption by up to 45% with no changes to building infrastructure. Active deployments across 12 European cities.
France • Seed Round, August 2022 • $5M
Neuromorphic processor architecture delivering 50x energy efficiency gains for edge AI inference. Targeting autonomous vehicles, robotics, and industrial IoT applications at unprecedented performance-per-watt ratios.
United Kingdom • Seed Round, October 2024 • $5M
Photonic quantum computing platform with room-temperature qubits. Proprietary waveguide fabrication process enables high-fidelity quantum gates without cryogenic cooling, removing the largest barrier to commercial quantum deployment.
Netherlands • Seed Round, May 2024 • $5M
Phase-change memory technology with 10x read/write speed improvement over NAND flash and near-DRAM latency. Enabling new memory hierarchy architectures for AI training systems and edge inference applications.
Germany • Seed Round, January 2024 • $5M
Silicon photonics interconnect technology for data centres. Replaces copper with optical waveguides on-chip, delivering 100Gbps per lane with 5x reduction in power consumption at the chip-to-chip communication layer.
Sweden • Seed Round, April 2023 • $5M
AI-optimised compiler and runtime for heterogeneous compute environments. Automatically generates optimal code across CPU, GPU, and specialised accelerator targets. Demonstrates 3.5x throughput gains for transformer model inference.
United Kingdom • Seed Round, August 2023 • $5M
Cryogenic CMOS control electronics for quantum computing systems. Operates reliably at 4K, eliminating the room-temperature control bottleneck that limits qubit counts in current quantum computers. Enabling 1,000+ qubit systems.
Denmark • Seed Round, September 2022 • $5M
mRNA-based precision medicine platform for rare autoimmune diseases. Pipeline of six therapeutic candidates with breakthrough designation potential. Proprietary delivery system achieves targeted tissue distribution without off-target immunogenicity.
United Kingdom • Seed Round, February 2025 • $5M
Point-of-care molecular diagnostic platform enabling 15-minute PCR-quality results without laboratory infrastructure. Targeting high-volume infectious disease testing in resource-limited settings across Southeast Asia and Sub-Saharan Africa.
Netherlands • Seed Round, July 2024 • $5M
Small molecule senolytic compounds targeting cellular senescence pathways associated with age-related disease. Lead compound demonstrates 40% reduction in disease biomarkers in phase I safety study. Phase II initiation planned for 2026.
Germany • Seed Round, March 2024 • $5M
Foundation model for de novo molecular design, trained on 200M+ experimental data points. Reduces lead identification timelines by 4x compared to traditional high-throughput screening. Three pharmaceutical partnerships signed in 2025.
Sweden • Seed Round, November 2023 • $5M
Miniaturised robotic surgical system for minimally invasive procedures in confined anatomical spaces. Sub-millimetre precision instruments with haptic force feedback. CE Mark received for orthopaedic applications in 2025.
France • Seed Round, June 2023 • $5M
Precision live biotherapy products targeting the gut-brain axis for neurological and metabolic conditions. Proprietary strain discovery platform identifies novel commensals with disease-modifying activity. First candidate in Phase I clinical trial.
United Kingdom • Seed Round, January 2023 • $5M